UNSPSC 51282532: Cefazolin sodium

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P380M0454Z. European Medicines Agency schedules Cefazolin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01107MIG. Cefazolin sodium generally arises in the molecular formula C14H13N8NAO4S3. The term 'cefazolin sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cefazolin sodium under HS 29419000.

As of Q4 2014, CEFAZOLIN SODIUM remains US FDA's Preferred Term for this commodity. Cefazolin sodium bears US NLM identifiers UMLS ID C0700526 and NCI Concept Code C47968. SMILES: CC1NNC(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4CNNN4)SC2)C(=O)[O-].[NA+].

UNSPSC 51282532 Cefazolin sodium is a Commodity code, but the recent state and local opportunities posted under it do not align with procurement of this specific pharmaceutical agent. Instead, the tagged solicitations span broader pharmaceutical and medical supply categories—naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products. State and local governments are using this code tag to buy emergency response medications, pharmacy benefit management infrastructure, and bulk medical consumables for fire departments, health agencies, and cooperative purchasing alliances, rather than cefazolin sodium specifically.

The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), city purchasing offices (Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple states including Oregon). Recent activity spans Florida, Texas, and the Upper Midwest and Pacific regions covered by MMCAP. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually with a response deadline of July 26, 2023; the City of Tampa's IFB for medical and first aid supplies ($700,000 estimated contract value, sheltered to certified Small Local Business Enterprises, response deadline March 13, 2026); the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (response deadline March 26, 2026). The mismatch between the code's nominal scope (cefazolin sodium) and actual procurement activity suggests this code may be misapplied in the source data or that the tag does not reliably predict the work being solicited.